Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1442-200X.2009.02872.xDOI Listing

Publication Analysis

Top Keywords

growth hormone
4
hormone therapy
4
therapy sisters
4
sisters shox
4
shox haploinsufficiency
4
growth
1
therapy
1
sisters
1
shox
1
haploinsufficiency
1

Similar Publications

Background: In people with HIV (PWH) who are virally suppressed (VS) on antiretroviral therapy (ART), abdominal obesity (AO) is linked to neurocognitive impairment (NCI), potentially due to visceral adiposity, inflammation, and reduced insulin-like growth factor 1 (IGF-1). Tesamorelin, a growth hormone-releasing hormone, reduces AO and increases IGF-1, suggesting it might mitigate NCI in VS PWH.

Methods: This 6-month, Phase II randomized, open-label clinical trial compared Tesamorelin versus standard-of-care (SOC) for NCI in abdominally obese PWH.

View Article and Find Full Text PDF

Ghrelin, the endogenous ligand of the growth hormone secretagogue receptor (GHSR), promotes food intake, other feeding behaviours and stimulates growth hormone (GH) release from the pituitary. Growth hormone secretagogues (GHS), such as GHRP-6 and MK-0677, are synthetic GHSR ligands that activate orexigenic Neuropeptide Y neurons that co-express Agouti-Related Peptide (AgRP) in the arcuate nucleus of the hypothalamus when administered systemically. Systemic GHRP-6 also stimulates GH release in humans and rats.

View Article and Find Full Text PDF

Melatonin (MLT) is an indole derivative that exhibits hormone-like activities in plants, regulating multiple aspects of growth and development. Due to its role in mitigating oxidative stress and facilitating osmoprotectant accumulation, MLT enhances abiotic stress tolerance, although the pathways and metabolic mechanisms involved remain unclear despite being studied in various crops. This work aimed to investigate the changes elicited by the exogenous MLT application at different concentrations (10, 50, 150 μM) and its role in mitigating the salinity stress in Lactuca sativa L.

View Article and Find Full Text PDF

Purpose: Growth hormone deficiency (GHD) causes decreased growth rate in children, resulting in short stature in childhood and adulthood. Daily subcutaneous injections with growth hormone (GH) have been standard treatment. Newer weekly GH formulations now exist.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!